Data Science in Biomedical Research at Novartis

AI Quick Summary

Novartis is a global pharmaceutical company which invests many resources into biological research to understand disease biology and find potential therapies. Data science of many various flavors has emerged as a critical competency to analyze and use the vast amounts of pre-clinical and clinical data that is being produced in our research departments.Dr. Stefan Reinker will give a general overview of the focus disease areas and research efforts and then give more specific examples of the data processing and analysis workflows of sequencing data used in genomics research for characterizing single cell and spatial transcriptomics.

Event Metadata

• Event Name: Data Science in Biomedical Research at Novartis
• Date: 11/7/2024 11:35:53 AM
• Administrators:
  • Switzerland Innovation Digital

Event Description

Novartis is a global pharmaceutical company which invests many resources into biological research to understand disease biology and find potential therapies. Data science of many various flavors has emerged as a critical competency to analyze and use the vast amounts of pre-clinical and clinical data that is being produced in our research departments.

Dr. Stefan Reinker will give a general overview of the focus disease areas and research efforts and then give more specific examples of the data processing and analysis workflows of sequencing data used in genomics research for characterizing single cell and spatial transcriptomics.